Lung Microbiome-Estrogen Interaction May Explain Why Women Are More Susceptible to Genetic Pulmonary Hypertension
A new study identifies a mechanism linking lung microbiome composition, estrogen metabolism, and immune activation that may explain why women with a specific BMPR2 gene mutation develop pulmonary arterial hypertension more often than men. The research, conducted in mice, shows that females develop a distinct microbiome profile that triggers macrophages to produce elevated levels of endothelin-1, a potent blood vessel constrictor. This finding could help explain long-standing sex disparities in genetic pulmonary hypertension and potentially guide new therapeutic approaches.
Researchers using humanized mouse models discovered that females with a BMPR2 R899X mutation—a major genetic driver of pulmonary arterial hypertension (PAH)—develop a distinct lung microbiome characterized by increased lipopolysaccharide-producing bacteria. This microbial profile, combined with the estrogen metabolite 16-hydroxyestrone, activates macrophages to enter a hyperactivated state that produces elevated levels of endothelin-1 (ET-1), a potent vasoactive molecule that constricts blood vessels. Tissue analyses confirmed immune cell infiltration and spatial association with elevated ET-1 levels. The study identifies what the authors call a previously unrecognized microbiome-estrogen-immune axis that amplifies BMPR2 dysfunction. This mechanism provides a potential biological explanation for the striking sex bias in PAH penetrance, where females are disproportionately affected despite carrying the same mutation as males.
What's missing
The study's own limitations include reliance on mouse models, which may not fully recapitulate human disease; the specific mechanisms by which 16-hydroxyestrone and LPS synergistically activate macrophages require further investigation; and whether microbiome-targeted interventions could therapeutically reverse or prevent disease in humans remains untested.
What different sources said
- bioRxivCenter
Sex-linked Lung Estrobolome May Contribute to Pulmonary Hypertension Penetrance of Bmpr2 R899X Mutation via an ET-1high Endoregulatory Macrophage Phenotype
Related
Study Shows Statins Reduce Coenzyme Q in Brain Cells, Impairing Mitochondrial Function
A laboratory study found that statin drugs decrease coenzyme Q levels in astrocytes (brain support cells) by 30-40%, reducing their mitochondrial energy production and increasing oxidative stress. Astrocytes are critical for maintaining brain health and protecting neurons from damage. The findings suggest CoQ10 supplementation may help counteract these effects, though human clinical evidence remains limited.
Study reveals zebrafish larvae exhibit slowly fluctuating directional swim biases driven by internal dynamics
Researchers found that 5-day-old zebrafish larvae display changing directional swim preferences over many hours even in stable environments, contrary to classical models assuming constant individual biases. Computational analysis suggests these fluctuations arise from a non-stationary Markovian process with two independent internal input streams modulating swim direction repetition. The findings suggest animals possess intrinsic mechanisms for generating behavioral variability independent of external stimuli, with implications for understanding how internal states shape adaptive behavior.
Two Small Molecules Show Promise as Broad-Spectrum Coronavirus Inhibitors in Laboratory Study
Researchers found that sennoside A and ceftazidime, two small molecules, can inhibit RNA binding in the nucleocapsid proteins of SARS-CoV-2, SARS-CoV, and MERS-CoV in laboratory experiments. The nucleocapsid protein is highly conserved across coronaviruses and essential for viral replication, making it a potential drug target. The findings suggest these compounds could form the basis for pan-coronavirus antiviral therapies, though further development and clinical testing would be needed.